Actively Recruiting

Age: 18Years +
All Genders
NCT06877637

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Led by Region Skane · Updated on 2025-05-25

150

Participants Needed

3

Research Sites

241 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The BILLIONSTARS study is a prospective, single arm observational study inviting patients diagnosed with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) who are to be recommended locoregional intervention by surgery, ablation or transarterial chemoembolization and/or antitumoral medical treatment. The aim is to investigate how tumor- and individual-related factors affect response to treatment. To this end, circulating tumor DNA, immune cells and various proteins will be analyzed in repeated blood samples taken before, during and after completion of systemic treatment. When applicable, analyses will also be performed on tumor tissue from resected tumors and biopsies, and in some cases also from autopsies

CONDITIONS

Official Title

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Older than 18 years of age
  • Diagnosed with intrahepatic, perihilar, distal cholangiocarcinoma, gall bladder carcinoma, mixed hepatocellular carcinoma/cholangiocarcinoma planned for surgery
  • Histological or cytological confirmation of cholangiocarcinoma for patients planned to receive palliative systemic treatment
  • Diagnosed with hepatocellular carcinoma planned for surgery, ablation, or transarterial chemoembolization
  • Histological or cytological confirmation of hepatocellular carcinoma required for systemic treatment unless LI-RADS 5 lesion
Not Eligible

You will not qualify if you...

  • Younger than 18 years of age
  • Severe other medical conditions
  • Unable to understand study information

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Onkologimottagning Central Hospital in Kristianstad

Kristianstad, Sweden, 29185

Actively Recruiting

2

VE Onkologi Skåne University Hospital

Lund, Sweden, 22185

Actively Recruiting

3

VO kirurgi och gastroenterologi Skåne University Hospital

Lund, Sweden, 22185

Not Yet Recruiting

Loading map...

Research Team

K

Karin Jirström, PhD, MD, professor

CONTACT

P

Philip Falk, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here